These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 30765268)

  • 21. [Prognostic factors of patients with unresectable liver metastasis from colorectal cancer after failed conversion chemotherapy].
    He H; Shen W; Chen W; Liu H; Gong W; Fu J; Hu X; Cui L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Nov; 21(11):1261-1267. PubMed ID: 30506537
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of Metastatic Colorectal Cancer Patients ≥75 Years Old in Clinical Practice: A Multicenter Analysis.
    Grande R; Natoli C; Ciancola F; Gemma D; Pellegrino A; Pavese I; Garufi C; Di Lauro L; Corsi D; Signorelli D; Sperduti I; Cortese G; Risi E; Morano F; Sergi D; Signorelli C; Ruggeri EM; Zampa G; Russano M; Gamucci T
    PLoS One; 2016; 11(7):e0157751. PubMed ID: 27442239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemotherapy delivery for resected colorectal cancer liver metastases: Management and outcomes in routine clinical practice.
    Krishnamurthy A; Kankesan J; Wei X; Nanji S; Biagi JJ; Booth CM
    Eur J Surg Oncol; 2017 Feb; 43(2):364-371. PubMed ID: 27727025
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Addition of Bevacizumab to First-Line Chemotherapy for Metastatic Colorectal Cancer.
    Tsutsumi S; Fujii T; Yamaguchi S; Suto T; Yajima R; Morita H; Kato T; Asao T; Kuwano H
    Hepatogastroenterology; 2014 May; 61(131):633-7. PubMed ID: 26176048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comorbidity assessment to determine prognosis in older adult patients with classical Hodgkin lymphoma.
    Galli E; Cuccaro A; Maiolo E; Bellesi S; D'Alò F; Fusco D; Colloca G; De Stefano V; Hohaus S
    Hematol Oncol; 2020 Apr; 38(2):153-161. PubMed ID: 31953864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of palliative chemotherapy in metastatic colorectal cancer patients with an ECOG performance status of 3 and 4.
    Crosara Teixeira M; Marques DF; Ferrari AC; Alves MF; Alex AK; Sabbaga J; Hoff PM; Riechelmann RP
    Clin Colorectal Cancer; 2015 Mar; 14(1):52-7. PubMed ID: 25442812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of Comorbidities in Stage II/III Colorectal Cancer Patients Treated With Surgery and Neoadjuvant/Adjuvant Chemotherapy: A Single-Center, Observational Study.
    Baretti M; Rimassa L; Personeni N; Giordano L; Tronconi MC; Pressiani T; Bozzarelli S; Santoro A
    Clin Colorectal Cancer; 2018 Sep; 17(3):e489-e498. PubMed ID: 29650416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcome and natural history of patients with stage IV colorectal cancer receiving chemotherapy without primary tumor resection.
    Nitzkorski JR; Farma JM; Watson JC; Siripurapu V; Zhu F; Matteotti RS; Sigurdson ER
    Ann Surg Oncol; 2012 Feb; 19(2):379-83. PubMed ID: 21861213
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Benefit of Adjuvant Chemotherapy After Curative Resection of Lung Metastasis in Colorectal Cancer.
    Park HS; Jung M; Shin SJ; Heo SJ; Kim CG; Lee MG; Beom SH; Lee CY; Lee JG; Kim DJ; Ahn JB
    Ann Surg Oncol; 2016 Mar; 23(3):928-35. PubMed ID: 26514121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Capecitabine monotherapy as salvage treatment after failure of chemotherapy containing oxaliplatin and irinotecan in patients with metastatic colorectal cancer.
    Kim ST; Choi YJ; Park KH; Oh SC; Seo JH; Shin SW; Kim JS; Kim YH
    Asia Pac J Clin Oncol; 2011 Mar; 7(1):82-7. PubMed ID: 21332655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. KRAS Status as a Predictor of Chemotherapy Activity in Patients With Metastatic Colorectal Cancer.
    Yarom N; Gresham G; Boame N; Jonker D
    Clin Colorectal Cancer; 2019 Dec; 18(4):e309-e315. PubMed ID: 31547963
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary Tumor Resection Offers Higher Survival Advantage in KRAS Mutant Metastatic Colorectal Cancer Patients.
    Kodaz H; Erdogan B; Hacibekiroglu I; Turkmen E; Tozkir H; Albayrak D; Uzunoglu S; Cicin I
    Hepatogastroenterology; 2015 Jun; 62(140):876-9. PubMed ID: 26902020
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Additional chemotherapy improved local control and overall survival after stereotactic body radiation therapy for patients with oligo-recurrence.
    Nakamura M; Hashimoto N; Mayahara H; Uezono H; Harada A; Nishikawa R; Matsuo Y; Kawaguchi H; Nishimura H
    Radiat Oncol; 2018 Apr; 13(1):75. PubMed ID: 29688858
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perioperative chemotherapy with or without bevacizumab in patients with metastatic colorectal cancer undergoing liver resection.
    Constantinidou A; Cunningham D; Shurmahi F; Asghar U; Barbachano Y; Khan A; Mudan S; Rao S; Chau I
    Clin Colorectal Cancer; 2013 Mar; 12(1):15-22. PubMed ID: 23021126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of comorbidity on tolerability and survival following curative intent intensity modulated radiotherapy in older patients with nasopharyngeal cancer.
    Sommat K; Yit NLF; Wang F; Lim JHC
    J Geriatr Oncol; 2018 Jul; 9(4):352-358. PubMed ID: 29429963
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of neutrophil-to lymphocyte ratio and platelet-to lymphocyte ratio in older patients with metastatic colorectal cancer.
    Cruz-Ramos M; Del Puerto-Nevado L; Zheng B; López-Bajo R; Cebrian A; Rodríguez-Remirez M; García-García L; Solanes-Casado S; García-Foncillas J
    J Geriatr Oncol; 2019 Sep; 10(5):742-748. PubMed ID: 30327283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comorbidities Predict Inferior Survival in Patients Receiving Chimeric Antigen Receptor T Cell Therapy for Diffuse Large B Cell Lymphoma: A Multicenter Analysis.
    Kittai AS; Huang Y; Gordon M; Denlinger N; Mian A; Fitzgerald L; Bishop J; Nagle S; Stephens DM; Jaglowski S; Hill B; Danilov AV
    Transplant Cell Ther; 2021 Jan; 27(1):46-52. PubMed ID: 33002640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes of irinotecan-based chemotherapy regimens in elderly Medicare patients with metastatic colorectal cancer.
    Obeidat NA; Pradel FG; Zuckerman IH; DeLisle S; Mullins CD
    Am J Geriatr Pharmacother; 2009 Dec; 7(6):343-54. PubMed ID: 20129255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Baseline quality of life and performance status as prognostic factors in patients with extensive-stage disease small cell lung cancer treated with pemetrexed plus carboplatin vs. etoposide plus carboplatin.
    Reck M; Thatcher N; Smit EF; Lorigan P; Szutowicz-Zielinska E; Liepa AM; Winfree KB; Peterson P; Guba SC; Socinski MA
    Lung Cancer; 2012 Dec; 78(3):276-81. PubMed ID: 23043970
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatic Arterial Infusion Chemotherapy for Unresectable Liver Metastases of Colorectal Cancer: A Multicenter Retrospective Study.
    Lim A; Le Sourd S; Senellart H; Luet D; Douane F; Perret C; Bouvier A; Métairie S; Cauchin E; Rougier P; Matysiak-Budnik T; Touchefeu Y
    Clin Colorectal Cancer; 2017 Dec; 16(4):308-315. PubMed ID: 28433600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.